Glenmark Pharmaceuticals Ltd.
Share Price Target & Analysis

NSE:GLENMARK

2314.74

VWAP

2247.9

Open

2240

Close

2359.4

High

2212.1

Low

2359.4

52 Week High

2335.00 ⇧
95.00 (4.24%)

GLENMARK

(PHARMA)
97.6% Momentum

Trending & Favourite

1355

52 Week Low

0.74

EPS

39.88

PE

2.72

PB

Economical
Quality

Diamond
Valuation

#Analysis

NSE: GLENMARK Share Price Financial Analysis & Valuation

Glenmark Pharmaceuticals Ltd. (GLENMARK) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Mid Cap company with Market Capitalization of Rs 13448.1 (in Cr). Total number of free float shares are 0 (in Lacs). Glenmark Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE935A01035 and trading code is NSE:GLENMARK with short name Glenmark.

Glenmark Pharmaceuticals Ltd. is also traded in Future & Options (Derivative segment of NSE).

In the past 1 year, Glenmark Pharmaceuticals Ltd. has declared an equity dividend of Rs 2.5 per share. At the current share price of GLENMARK at Rs 2335.00, this results in a dividend yield of 0.11 %.

As per the Fundamental Analysis of NSE:GLENMARK, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLENMARK underlying value and future prospects. All of this data is available in GLENMARK financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:GLENMARK, it is clearly understood that GLENMARK is Economical performer in terms of earnings and profit margins with an EPS of 0.74. NSE:GLENMARK book value per share as of today is 858.31. The current price to book ratio for GLENMARK as of Apr 24, 2026 is 2.72.

Valuation of the Stock: The current valuation of GLENMARK stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLENMARK whether to BUY this stock at current valuation. The delivery percentage of GLENMARK is 47.98% is very crucial parameter which shows that 47.98% investors are anticipating that the price of GLENMARK share should go up with VWAP at 2314.74.

Now, the main question is whether to BUY or SELL, NSE:GLENMARK at current valuation.
As per latest Analysis No. #1628:-

⇑ STRONG BUY GLENMARK if All Greens

⇗ BUY GLENMARK (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD GLENMARK (With Stop Loss) if only 1 Green

⇘ SELL GLENMARK if NO Green Indicator

NSE: GLENMARK Share Price Today (Apr 24, 2026)

(Glenmark Pharmaceuticals Ltd. Daily Analysis on the basis of GLENMARK Intraday Graph & Trend)

Glenmark Pharmaceuticals Ltd. share price moved Up by 4.24% from its previous close of Rs 2240. GLENMARK stock last traded price is 2335.00. GLENMARK share price trend is Up with a total of 1703420 stocks traded till now. It has touched an intraday high of Rs 2359.4 and an intraday low of Rs 2212.1. The GLENMARK trading at 2335.00, Up by Rs. 95.00, or 4.24 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Up.

NSE: GLENMARK Share Price Tomorrow Prediction

(Glenmark Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLENMARK)

Glenmark Pharmaceuticals Ltd. share price moved Up by 4.24%. GLENMARK share price short term trend is Up. It suggests that GLENMARK Share Price for Tomorrow remains the same with VWAP at 2314.74 will be treated as stop loss for intraday traders. Glenmark Pharmaceuticals Ltd. Long term investors can follow the GLENMARK long term trend as mentiond in future forecast table.

NSE Code

NSE: GLENMARK

GLENMARK Share Price Today

 2335.00

GLENMARK Share Price Target Prediction for 2026 ^

 1785.9 - 2371.1

GLENMARK Share Price Target Prediction for 2027*^

 2371.1 - 2465.9

GLENMARK Share Price Target Prediction for 2028*^

 2465.9 - 2589.2

GLENMARK Share Price Target Prediction for 2029*^

 2719

GLENMARK Share Price Target Prediction for 2030*^

 2745

GLENMARK Share Price Target Prediction for 2035*^

 2964
GLENMARK Current Book Value 2025
854

*Glenmark Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLENMARK share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

GLENMARK Technical Analysis

Candlestick Pattern: @2181.1

GLENMARK Moving Averages

BUY (14) NEUTRAL (0) SELL (0)
MA Simple Action S1 Expo Action E2
MA_5 1918.9 BUY 1957.5 BUY
MA_12 1818.98 BUY 1843.53 BUY
MA_20 1764.38 BUY 1786.1 BUY
MA_32 1669.86 BUY 1706.66 BUY
MA_50 1590.67 BUY 1649.11 BUY
MA_100 1518.52 BUY 1580.57 BUY
MA_200 1541.95 BUY 1498.98 BUY

GLENMARK Trend Oscillators

BUY (4) NEUTRAL (0) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 2007.43 OverBought
MACD 26.02 BUY
ADX 52.86 Very Strong Trend
DMI (+/-) 64.03 / 5.72 Uptrend

GLENMARK Momentum Oscillators

BUY (6) NEUTRAL (5) SELL (1)
Momentum Oscillators Value Action
RSI 88.37 Overbought
STOCHASTIC_K (Fast) 78.89 Neutral
STOCHASTIC_D (Slow) 69.52 Neutral
CCI 317.8 BUY
PSAR 1792.6 BUY
TRUE RANGE 380.8 Neutral
ATR 69.92 SELL
WILLIAMS R -16.99 Overbought
TRIX 0 Neutral
STOCHASTIC RSI K 100 Overbought
STOCHASTIC RSI D 53.15 Neutral
MOMENTUM 541.5 BUY

GLENMARK Last 1 Year Trend

Duration Value
1 Year 60.49%
3 Months 51.23%
1 Month 33.03%
1 Week 19.16%

GLENMARK Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 80%
NEUTRAL / HOLD 17%
SELL 3%

Most popular Questions & Answers about GLENMARK


Glenmark Pharmaceuticals Ltd. stock last traded price is 2335.00. GLENMARK share price moved Up by 4.24% from its previous close of Rs 2240.

Glenmark Pharmaceuticals Ltd. share price trend is Up with a total of 1703420 stocks traded till now. It has touched an intraday high of Rs 2382.994 and an intraday low of Rs 2212.1. The GLENMARK trading at 2335.00, Up by Rs. 95.00, or 4.24 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Up and the Stop Loss will be around 2314.74.

The market cap of Glenmark Pharmaceuticals Ltd. is ₹13448.1 (in Cr) as of Apr 23, 2026.

The current price to earning ratio for Glenmark Pharmaceuticals Ltd. as of Apr 23, 2026 is 39.88.

The current price to book ratio for Glenmark Pharmaceuticals Ltd. as of Apr 23, 2026 is 2.72.

The highest price of Glenmark Pharmaceuticals Ltd. stock is ₹2359.4 in the last 52-week.

The lowest price of Glenmark Pharmaceuticals Ltd. stock is ₹1355 in the last 52-week.

Glenmark Pharmaceuticals Ltd. share trading at ₹2335.00, Up by Rs. 95.00, or 4.24 percent which suggests that most of the traders are anticipating that the price of GLENMARK share should go Up.

In 2025, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1785.9 on downside and ₹2371.1 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.

In 2026, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2371.1 on downside and ₹2465.9 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2465.9 on downside and ₹2589.2 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2745 Glenmark Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLENMARK.

The price of Glenmark Pharmaceuticals Ltd. (GLENMARK) shares moved by 4.24%. The short-term trend for GLENMARK share price is Up. It implies that the share price of GLENMARK will stay the same tomorrow and that intraday traders should treat VWAP at 2314.74 as a stop loss. Investors with a long-term outlook can track GLENMARK long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of GLENMARK stock is 8.9. Compared to the current market price of 2335.00 INR, the GLENMARK stock is Overvalued by 99.6%.

As per the fundamental analysis of Glenmark Pharmaceuticals Ltd. (GLENMARK), it is of Economical quality in terms of earnings and profit margins with an EPS of 0.74. Glenmark Pharmaceuticals Ltd. book value per share as of today is 858.31. The current price to book ratio for GLENMARK as of Apr 24, 2026 is 2.72.


NSE:GLENMARK News & Other Useful Information about GLENMARK Share Price


Peer Comparison of NSE: GLENMARK

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1680.10 16.77 102.19
DIVISLAB 6378.50 94.85 600.79
MEDICAMEQ 259.48 6.52 202.47
CIPLA 1305.90 57.14 419.19
DRREDDY 1331.00 55.59 378.64
PGHH 5215.00 189.8 373.34
TORNTPHARM 4147.20 64.97 266.87
BIOCON 358.00 0.05 99.01
LUPIN 2341.40 120.18 611.19
ALKEM 5520.50 195.87 1194.91
Updated at: 23 Apr 2026 15:42

Feel free to contact us, in case of any queries.

SITEMAP 3088
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2300.00 39.20 (1.73%) | ADANIGREEN 1214.15 15.20 (1.27%) | ADANIPORTS 1602.90 14.30 (0.9%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 450.40 -10.50 (-2.28%) | APOLLOHOSP 7781.00 119.00 (1.55%) | ASIANPAINT 2521.40 -41.50 (-1.62%) | ATGL 621.70 -7.40 (-1.18%) | AUROPHARMA 1435.40 14.20 (1%) | AXISBANK 1369.60 -10.00 (-0.72%) | BAJAJ-AUTO 9550.50 -51.50 (-0.54%) | BAJAJFINSV 1792.60 -50.30 (-2.73%) | BAJFINANCE 918.35 -16.40 (-1.75%) | BALKRISIND 2265.40 -44.30 (-1.92%) | BANDHANBNK 173.90 -2.62 (-1.48%) | BANKBARODA 276.34 -6.43 (-2.27%) | BEL 449.95 1.25 (0.28%) | BERGEPAINT 468.65 -9.60 (-2.01%) | BHARTIARTL 1841.20 12.20 (0.67%) | BIOCON 358.00 0.20 (0.06%) | BOSCHLTD 37380.00 -505.00 (-1.33%) | BPCL 309.80 -4.60 (-1.46%) | BRITANNIA 5671.50 -58.00 (-1.01%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1305.90 69.60 (5.63%) | COALINDIA 450.65 6.50 (1.46%) | COLPAL 2150.20 31.90 (1.51%) | DABUR 460.00 0.00 (0%) | DIVISLAB 6378.50 93.00 (1.48%) | DLF 592.80 -17.85 (-2.92%) | DMART 4521.20 -73.60 (-1.6%) | DRREDDY 1331.00 114.00 (9.37%) | EICHERMOT 7092.50 -137.50 (-1.9%) | GAIL 164.96 -1.16 (-0.7%) | GLAND 1795.40 -5.20 (-0.29%) | GODREJCP 1142.95 3.40 (0.3%) | GRASIM 2735.00 -41.60 (-1.5%) | GUJGASLTD 386.00 3.15 (0.82%) | HAVELLS 1260.30 -88.40 (-6.55%) | HCLTECH 1277.60 -7.70 (-0.6%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2708.20 -58.20 (-2.1%) | HDFCBANK 784.35 -15.55 (-1.94%) | HDFCLIFE 598.65 -5.40 (-0.89%) | HEROMOTOCO 5032.00 -157.00 (-3.03%) | HINDALCO 1041.35 1.45 (0.14%) | HINDUNILVR 2366.40 -2.40 (-0.1%) | HINDZINC 592.10 -12.65 (-2.09%) | ICICIBANK 1348.00 -19.60 (-1.43%) | ICICIGI 1809.90 -19.10 (-1.04%) | ICICIPRULI 535.30 -4.75 (-0.88%) | INDIGO 4556.00 -84.90 (-1.83%) | INDUSINDBK 860.35 -9.75 (-1.12%) | INDUSTOWER 404.70 -3.45 (-0.85%) | INFY 1240.60 -28.00 (-2.21%) | IOB 35.14 -0.25 (-0.71%) | IOC 145.48 -1.88 (-1.28%) | ITC 305.30 -0.20 (-0.07%) | JSWSTEEL 1257.00 -6.40 (-0.51%) | KOTAKBANK 370.40 -6.45 (-1.71%) | LT 4054.10 33.00 (0.82%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2341.40 33.50 (1.45%) | M&M 3047.70 -102.00 (-3.24%) | MARICO 778.90 6.40 (0.83%) | MARUTI 13160.00 -177.00 (-1.33%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 3561.40 -25.50 (-0.71%) | NAUKRI 1018.05 -34.65 (-3.29%) | NESTLEIND 1410.50 14.70 (1.05%) | NMDC 87.31 -1.28 (-1.44%) | NTPC 402.25 -3.15 (-0.78%) | ONGC 286.25 2.60 (0.92%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1402.10 -16.90 (-1.19%) | PIIND 3069.60 12.30 (0.4%) | PNB 112.71 -1.96 (-1.71%) | POWERGRID 319.15 -0.60 (-0.19%) | RELIANCE 1343.40 -18.70 (-1.37%) | SAIL 176.45 0.22 (0.12%) | SBICARD 680.55 -5.65 (-0.82%) | SBILIFE 1828.10 -56.70 (-3.01%) | SBIN 1094.25 -9.05 (-0.82%) | SHREECEM 25470.00 -265.00 (-1.03%) | SIEMENS 3864.40 20.10 (0.52%) | SRF 2542.40 49.60 (1.99%) | SUNPHARMA 1680.10 10.30 (0.62%) | TATACONSUM 1184.40 5.80 (0.49%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 210.91 -2.12 (-1%) | TCS 2521.80 -16.70 (-0.66%) | TECHM 1421.50 -41.10 (-2.81%) | TITAN 4456.50 1.90 (0.04%) | TORNTPHARM 4147.20 62.60 (1.53%) | ULTRACEMCO 12167.00 -26.00 (-0.21%) | UPL 642.05 -11.80 (-1.8%) | VEDL 735.60 -21.40 (-2.83%) | WIPRO 202.76 -1.24 (-0.61%) |